BrainStorm Cell Therapeutics
BCLI
#9833
Rank
A$1.83 M
Marketcap
$0.35
Share price
3.51%
Change (1 day)
11.02%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.89

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.88. In 2022 the company made an earnings per share (EPS) of -$0.99 an increase over its 2021 EPS that were of -$1.02.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-10.04%
2022-$0.99-2.94%
2021-$1.02-37.04%
2020-$1.621.89%
2019-$1.5951.43%
2018-$1.05159.26%
2017-$0.40-3.57%
2016-$0.42-37.78%
2015-$0.67-33.82%
2014-$1.0236%
2013-$0.7511.11%
2012-$0.6750%
2011-$0.45-50%
2010-$0.90-233.33%
2009$0.67-142.86%
2008-$1.57-65%
2007-$4.50
2005$1.48-108.03%
2004-$18.5013203.07%
2003-$0.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$6.58-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.53 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.01 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.69-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.27 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA